ArticleCancer immunology, immunotherapy : CII2026
NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma.
Yuanyu Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.